Style | Citing Format |
---|---|
MLA | Amirkhizi F, et al.. "Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome." Nutrition and Metabolism, vol. 22, no. 1, 2025, pp. -. |
APA | Amirkhizi F, Taghizadeh M, Hamedishahraki S, Asghari S (2025). Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome. Nutrition and Metabolism, 22(1), -. |
Chicago | Amirkhizi F, Taghizadeh M, Hamedishahraki S, Asghari S. "Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome." Nutrition and Metabolism 22, no. 1 (2025): -. |
Harvard | Amirkhizi F et al. (2025) 'Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome', Nutrition and Metabolism, 22(1), pp. -. |
Vancouver | Amirkhizi F, Taghizadeh M, Hamedishahraki S, Asghari S. Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome. Nutrition and Metabolism. 2025;22(1):-. |
BibTex | @article{ author = {Amirkhizi F and Taghizadeh M and Hamedishahraki S and Asghari S}, title = {Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome}, journal = {Nutrition and Metabolism}, volume = {22}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Amirkhizi F AU - Taghizadeh M AU - Hamedishahraki S AU - Asghari S TI - Association of Dietary Phytochemical Index With Metabolic Markers, Serum Asymmetric Dimethylarginine and Atherogenic Indices in Patients With Polycystic Ovary Syndrome JO - Nutrition and Metabolism VL - 22 IS - 1 SP - EP - PY - 2025 ER - |